William E. Kennard - 08 Sep 2026 Form 4 Insider Report for METLIFE INC (MET)

Reporting relationship: Director
Issuer ticker: MET
Reported as of: 08 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Sep 2026, 16:02:39 UTC
Prior SEC filing: 03 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact

Key filing fact

William E. Kennard filed Form 4 for METLIFE INC (MET) on 10 Sep 2026.

Key facts

This page summarizes William E. Kennard's Form 4 filing for METLIFE INC (MET).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Sep 2026, 16:02.

Change

Previous filing in this sequence was filed on 03 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001198236 Primary reporting owner

Kennard William E

Relationship: Director
Address: METLIFE, INC., 200 PARK AVENUE, NEW YORK
Signature: /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact
Signature date: 10 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MET transaction

Common Stock

Award

Transaction value
Shares: +294
Change %: +0.62%
Price: $95.50^*
Shares after: 47,704
Date: 08 Sep 2026
Ownership: Direct
Footnotes: F1

MET holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10
Date: 08 Sep 2026
Ownership: By the MetLife Policyholder Trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Footnote F2

Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.